Outlook Therapeutics, Inc. has filed 813 documents with the SEC available on Filing Fan. Browse annual reports (10-K), quarterly reports (10-Q), earnings releases (8-K), proxy statements, and more on Filing Fan. Filing Fan provides income statements, balance sheets, cash flow statements, and segment data parsed directly from EDGAR filings. All financial data is sourced from publicly available SEC regulatory filings.
| Form | Date | Description |
|---|---|---|
| 4 | 2026-07-29 | Statement of Changes in Beneficial Ownership |
| 8-K | 2026-07-24 | Departure/Appointment of Directors or Officers |
| 8-K | 2026-07-24 | Other Events; Financial Statements and Exhibits |
| 4 | 2026-07-23 | Statement of Changes in Beneficial Ownership |
| 4 | 2026-07-23 | Statement of Changes in Beneficial Ownership |
| 424B3 | 2026-07-21 | 424B3 |
| S-3 | 2026-07-17 | Registration Statement (Shelf) |
| 8-K | 2026-07-16 | Amendments to Articles of Incorporation or Bylaws; Submission of Matters to a Vote of Security Holders |
| DEFA14A | 2026-07-10 | Additional Proxy Soliciting Materials |
| 8-K | 2026-06-26 | Notice of Delisting or Transfer |